Three Health Care Stocks Poised for Significant Gains This December
Oversold Stocks Opportunity: The health care sector has several oversold stocks, identified by a Relative Strength Index (RSI) below 30, indicating potential buying opportunities for undervalued companies.
Larimar Therapeutics Inc: The company reported a wider-than-expected quarterly loss, with its stock falling 20% over the past month and an RSI of 29.9, closing at $3.12.
Perrigo Company PLC: Perrigo's mixed financial results led to a 34% stock decline in the past month, with an RSI of 29.9, closing at $13.61, despite gaining market share in several categories.
ORIC Pharmaceuticals Inc: After a recent coverage initiation with an Outperform rating, ORIC's stock fell 16% over the past month, with an RSI of 29.6, closing at $10.65.
Get Free Real-Time Notifications for Any Stock
Analyst Views on LRMR
About LRMR
About the author
Larimar to Present at 44th J.P. Morgan Healthcare Conference on January 14, 2026
- Investor Meeting Participation: Larimar Therapeutics will participate in 1x1 investor meetings at the 44th J.P. Morgan Healthcare Conference on January 14, 2026, showcasing its advancements in treatments for complex rare diseases, which is expected to attract potential investor interest.
- Product Development Progress: The company's lead compound, nomlabofusp, is under development as a treatment for Friedreich's ataxia, and this innovation could open new market opportunities, enhancing its competitive position in the biotechnology sector.
- Webcast Arrangement: The presentation is scheduled from 9:00 to 9:40 AM PST, and investors can join via the provided webcast link, with a replay available for 30 days on the company’s website, thereby improving engagement with investors.
- Future Development Strategy: Larimar plans to leverage its intracellular delivery platform to design additional fusion proteins targeting more rare diseases, demonstrating the company's long-term growth potential and ongoing commitment to innovation in the biotechnology field.
Three Health Care Stocks Poised for Significant Gains This December
Oversold Stocks Opportunity: The health care sector has several oversold stocks, identified by a Relative Strength Index (RSI) below 30, indicating potential buying opportunities for undervalued companies.
Larimar Therapeutics Inc: The company reported a wider-than-expected quarterly loss, with its stock falling 20% over the past month and an RSI of 29.9, closing at $3.12.
Perrigo Company PLC: Perrigo's mixed financial results led to a 34% stock decline in the past month, with an RSI of 29.9, closing at $13.61, despite gaining market share in several categories.
ORIC Pharmaceuticals Inc: After a recent coverage initiation with an Outperform rating, ORIC's stock fell 16% over the past month, with an RSI of 29.6, closing at $10.65.
